Pharma Journalist 8962 posts 0 comments

The Future of Drug Delivery & Combination products SMi is proud to present their 11th leading annual european conference and exhibition, within the Pre-Filled Syringes series:…
Read More...

AstraZeneca announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion on a Type-II variation update…
Read More...

Myelo Therapeutics GmbH announced that the US Food and Drug Administration (FDA) has granted an Orphan Drug Designation to its orally applied new chemical entity Myelo001 for the…
Read More...

Infor announced that Ibnsina Pharma has invested in Infor EAM, Infor d/EPM, Infor M3, Infor SCE (Warehouse Management System), and Infor OS to help unify and integrate its business…
Read More...

Cerecor announced that it has agreed to acquire Ichorion Therapeutics, Inc. Ichorion is a privately-held biopharmaceutical company focused on developing treatments and increasing…
Read More...

PeptiDream announced that it has entered into a broad-based multi-target discovery and development agreement with Osaka-based Santen Pharmaceuticals. Under the agreement, PeptiDream…
Read More...

Tris Pharma announced the acquisition of NextWave Pharmaceuticals (NextWave), a wholly owned subsidiary of Pfizer Inc. (Pfizer), including two key Attention Deficit Hyperactivity…
Read More...

Sarepta Therapeutics announced that the Food and Drug Administration (FDA) has lifted the clinical hold for the Company’s Duchenne muscular dystrophy (DMD) micro-dystrophin gene therapy…
Read More...

AstraZeneca and MedImmune announced that the European Commission has granted marketing authorisation for Imfinzi (durvalumab) as monotherapy for the treatment of locally-advanced,…
Read More...

Gilead Sciences announced plans to launch authorized generic versions of Epclusa (sofosbuvir 400mg/velpatasvir 100mg) and Harvoni (ledipasvir 90mg/sofosbuvir 400mg), Gilead’s leading…
Read More...